CPSI and PipelineRx Bringing Telepharmacy Services to Community Hospitals
November 17 2016 - 10:00AM
Business Wire
CPSI Adds Remote Pharmacy Services to Aid
Small and Rural Hospitals with Efficiency, Quality of Care
CPSI (NASDAQ: CPSI), a leading provider of healthcare
information solutions, today announced that the Company has teamed
with PipelineRx to offer a cutting edge telepharmacy solution
designed to help small and rural community hospitals provide
first-class care. The remote pharmacy solution through PipelineRx
will be sold by TruBridge, the member of the CPSI family that
provides business, IT and management consulting and services.
“Adding remote, real-time medication order review and
verification services to our broad set of healthcare IT solutions
for community hospitals will help them overcome a very common
resource challenge,” said Boyd Douglas, president and chief
executive officer of CPSI.
San Francisco-based PipelineRx maintains a team of more than 100
experienced clinical pharmacists that uses best practices in
medication management and verification to ensure accuracy, quality,
safety, and optimal turnaround time 24/7. PipelineRx serves nearly
300 acute and specialty hospitals across the country.
“Our cost-effective model helps hospitals improve care and
medication safety for their patient populations,” said Brian
Roberts, chief executive officer of PipelineRx. “Our
technology-enabled telepharmacy services will bring measurable
clinical and fiscal value to acute and post-acute customers in the
CPSI family of companies, and we are pleased to be teaming up on
this collaborative, cloud-based solution.”
Douglas added, “We see this partnership as a great match for our
company and for our customers. Addressing this very real need for
additional resources fills our customers’ pharmaceutical coverage
gap with professional, secure and premium-quality pharmacy
services. We have begun the first phase of integration, which will
bring the functionality and workflow associated with telepharmacy
into our Evident and Centriq Electronic Health Records (EHR)
solutions for the hospital setting. Once we complete this phase, we
intend to integrate telepharmacy into our American HealthTech
solutions for our post-acute customers.
“The PipelineRx announcement is the latest in a series of
partnerships and product enhancements by CPSI designed to help
community providers and leaders navigate the changing world of
healthcare delivery, reimbursement and management,” Douglas
concluded.
About CPSI
CPSI is a leading provider of healthcare IT solutions and
services for rural and community hospitals and post-acute care
facilities. Founded in 1979, CPSI is the parent of five companies –
Evident, LLC, TruBridge, LLC, Healthland Inc., American HealthTech,
Inc., and Rycan Technologies, Inc. Our combined company is focused
on helping improve the health of the communities we serve,
connecting communities for a better patient care experience, and
improving the financial operations of our customers. Evident
provides comprehensive EHR solutions and services for rural and
community hospitals. TruBridge focuses exclusively on providing
business management, consulting and managed IT services to rural
and community healthcare organizations, regardless of their IT
vendor. Healthland provides integrated technology solutions and
services to small rural and critical access hospitals. American
HealthTech is one of the nation’s largest providers of financial
and clinical technology solutions and services for post-acute care
facilities. Rycan provides revenue cycle management and workflow
and automation software to hospitals, healthcare systems, and
skilled nursing organizations. For more information, visit
www.cpsi.com, www.evident.com, www.trubridge.com,
www.healthland.com, www.healthtech.net or www.rycan.com.
About PipelineRx
PipelineRx is the leading independent technology-enabled
telepharmacy solutions provider serving nearly 300 acute and
specialty hospitals. The Company’s pharmacy workforce solutions
enable hospitals to dramatically increase operating efficiencies
while ensuring medication efficacy, increasing patient safety, and
improving clinical outcomes. PipelineRx differentiates its unique
services via its integrated, private, cloud-based technology
platform and its optimized, distributed telepharmacist network.
PipelineRx is privately held and is headquartered in San Francisco,
California.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the "safe harbor" provisions of the Private
Securities Litigation Reform Act of 1995. These forward-looking
statements can be identified generally by the use of
forward-looking terminology and words such as "expects,"
"anticipates," "estimates," "believes," "predicts," "intends,"
"plans," "potential," "may," "continue," "should," "will" and words
of comparable meaning. Without limiting the generality of the
preceding statement, all statements in this press release relating
to estimated and projected earnings, margins, costs, expenditures,
cash flows, growth rates, shareholder returns and future financial
results are forward-looking statements. We caution investors that
any such forward-looking statements are only predictions and are
not guarantees of future performance. Certain risks, uncertainties
and other factors may cause actual results to differ materially
from those projected in the forward-looking statements. Such
factors may include: overall business and economic conditions
affecting the healthcare industry, including the potential effects
of the federal healthcare reform legislation enacted in 2010, and
implementing regulations, on the businesses of our hospital
customers; government regulation of our products and services and
the healthcare and health insurance industries, including changes
in healthcare policy affecting Medicare and Medicaid reimbursement
rates and qualifying technological standards; changes in customer
purchasing priorities, capital expenditures and demand for
information technology systems; saturation of our target market and
hospital consolidations; general economic conditions, including
changes in the financial and credit markets that may affect the
availability and cost of credit to us or our customers; our
substantial indebtedness, and our ability to incur additional
indebtedness in the future; our inability to generate sufficient
cash in order to meet our debt service obligations; restrictions on
our current and future operations because of the terms of our
senior secured credit facilities; market risks related to interest
rate changes; our ability to successfully integrate the businesses
of Healthland, American HealthTech and Rycan with our business and
the inherent risks associated with any potential future
acquisitions; competition with companies that have greater
financial, technical and marketing resources than we have; failure
to develop new or enhance current technology and products in
response to market demands; failure of our products to function
properly resulting in claims for losses; breaches of security and
viruses in our systems resulting in customer claims against us and
harm to our reputation; failure to maintain customer satisfaction
through new product releases or enhancements free of undetected
errors or problems; interruptions in our power supply and/or
telecommunications capabilities, including those caused by natural
disaster; our ability to attract and retain qualified customer
service and support personnel; failure to properly manage growth in
new markets we may enter; misappropriation of our intellectual
property rights and potential intellectual property claims and
litigation against us; changes in accounting principles generally
accepted in the United States; fluctuations in quarterly
financial performance due to, among other factors, timing of
customer installations; and other risk factors described from time
to time in our public releases and reports filed with
the Securities and Exchange Commission, including, but not
limited to, our most recent Annual Report on Form 10-K. We also
caution investors that the forward-looking information described
herein represents our outlook only as of this date, and we
undertake no obligation to update or revise any forward-looking
statements to reflect events or developments after the date of this
press release.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161117005175/en/
CPSITracey Schroeder, 612-787-3125Chief Marketing
Officertracey.schroeder@cpsi.com
Computer Programs and Sy... (NASDAQ:CPSI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Computer Programs and Sy... (NASDAQ:CPSI)
Historical Stock Chart
From Sep 2023 to Sep 2024